LoginSubscribe Now
International In-house Counsel Journal Logo
International In-house Counsel Journal Logo
  • Home
  • Business Sectors
  • Areas of Law
  • Editorial Board
  • Write a Paper
  • Subscribe
  • Books
  • Reports
  • Back Issues
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • PLS LogoCopyright & permissions
© 2026 International In-house Counsel Journal Ltd. | ISSN 1754-0607 | Picture Credits: Freepix, Unsplash and by permission of the authors

Library search

Implementing a Robust Compliance Program in a Remote Environment
ComplianceHealthcare
Implementing an effective Compliance program can be complicated and challenging in the best of times, especially when you operate globally in a rapidly changing environment. These challenges and complexities have...Read more
Portrait image of Laura Hamm
Laura Hamm
Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA
Managing Compliance Risk in a COVID and Post-COVID World
ManagementPharmaceutical
Managing risk can be complicated in the best of times, and the challenges associated with risk management become even greater when combined with the tremendous disruption caused by a global...Read more
Portrait image of Laura Hamm
Laura Hamm
Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA
What Makes a Great Compliance Leader?
ComplianceHealthcare
Great leaders exercise emotional intelligence, and they are very adept at understanding their strengths and weaknesses as well as those around them and can assess a situation pretty accurately and...Read more
Portrait image of Laura Hamm
Laura Hamm
Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA
Compliance Red Flags: What Companies Should Look Out For in Times of Change
ComplianceHealthcare
Although we know that compliance is everyone’s responsibility, we also understand that company personnel are focused on their primary roles and responsibilities, and because of this, compliance requirements may not...Read more
Portrait image of Laura Hamm
Laura Hamm
Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA